Ddavp and Demyelination - a phase IV clinical study of FDA data

Summary:

Demyelination is reported only by a few people who take Ddavp.

The phase IV clinical study analyzes which people take Ddavp and have Demyelination. It is created by eHealthMe based on reports of 2,362 people who have side effects while taking Ddavp from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

2,362 people reported to have side effects when taking Ddavp.
Among them, 2 people (0.08%) have Demyelination.

What is Ddavp?

Ddavp has active ingredients of desmopressin acetate. It is often used in diabetes insipidus. eHealthMe is studying from 2,443 Ddavp users for its effectiveness, alternative drugs and more.

What is Demyelination?

Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function) is found to be associated with 1,033 drugs and 644 conditions by eHealthMe.

Number of Ddavp and Demyelination reports submitted per year:

Gender of people who have Demyelination when taking Ddavp *:

female: 50 %
male: 50 %

Age of people who have Demyelination when taking Ddavp *:

Common drugs people take besides Ddavp *:

Levothyroxine Sodium: 1 person, 50.00%

Common side effects people have besides Demyelination *:

Malaise (a feeling of general discomfort or uneasiness): 1 person, 50.00%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 1 person, 50.00%
Hypoaesthesia (reduced sense of touch or sensation): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ddavp and have Demyelination?

Check whether Demyelination is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Demyelination and when was it recovered:

Demyelination in Ddavp

Expand to all the drugs that have ingredients of desmopressin acetate:

Demyelination and drugs with ingredients of desmopressin acetate

Alternative drugs to, pros and cons of Ddavp:

Ddavp (2,443 reports)

Common Ddavp side effects:

Browse all side effects of Ddavp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Demyelination treatments and more:

Demyelination (5,060 reports)

COVID vaccines that are related to Demyelination:

Common drugs associated with Demyelination:

Actemra: 350 reports
Arava: 353 reports
Aspirin: 199 reports
Atenolol: 195 reports
Avonex: 120 reports
Azathioprine: 280 reports
Baclofen: 112 reports
Cetirizine hydrochloride: 116 reports
Copaxone: 107 reports
Cyclosporine: 167 reports
Cymbalta: 162 reports
Diphenhydramine hydrochloride: 116 reports
Enbrel: 1,051 reports
Folic acid: 146 reports
Gilenya: 172 reports
Humira: 727 reports
Imuran: 153 reports
Leflunomide: 113 reports
Medrol: 125 reports
Methotrexate: 847 reports
Methotrexate sodium: 103 reports
Neurontin: 104 reports
Omeprazole: 122 reports
Orencia: 366 reports
Prednisolone: 146 reports
Prednisone: 357 reports
Prevacid: 138 reports
Remicade: 602 reports
Rituxan: 312 reports
Sulfasalazine: 192 reports
Tysabri: 114 reports
Xeljanz: 166 reports
Zopiclone: 142 reports

All the drugs that are associated with Demyelination:

Demyelination (1,033 drugs)

Common conditions associated with Demyelination:

Ankylosing spondylitis: 195 reports
Antidepressant therapy: 108 reports
Arthritis - rheumatoid: 805 reports
Crohn's disease: 323 reports
Crohns disease: 340 reports
Depression: 107 reports
High blood pressure: 135 reports
Hypertension: 133 reports
Hypertension aggravated: 136 reports
Inflammatory bowel disease - crohn's disease: 340 reports
Multiple sclerosis: 485 reports
Pain: 119 reports
Plaque psoriasis: 249 reports
Psoriasis: 261 reports
Psoriatic arthropathy: 180 reports
Psoriatic arthropathy aggravated: 195 reports
Ra: 723 reports
Regional enteritis: 340 reports
Rheumatoid arthritis: 805 reports
Spondylitis: 195 reports

All the conditions that are associated with Demyelination:

Demyelination (644 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on desmopressin acetate (the active ingredients of Ddavp) and Ddavp (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.